Buscar
Congreso SOLACI
HomeCoronary diseaseChronic Ischemic cardiopathy

Chronic Ischemic cardiopathy

Ver Categoría

Chronic Ischemic cardiopathy

ESC 2020 | Revascularization Strategies: Ventricular Dysfunction Might Tilt the Scales

Patients included in the ISCHEMIA trial who had a history of cardiac failure or ventricular function deterioration...
solaci -
Ver más
Chronic Ischemic cardiopathy

ESC 2020 | At Long Term, Diabetic Patients Benefit from Surgery

Data of this “real world” study have confirmed that diabetic patients with multivessel disease will benefit from...
solaci -
Ver más
Chronic Ischemic cardiopathy

ESC 2020 | Post PCI Trimetazidine: No Adverse Events or Great Benefits

Trimetazidine in addition to optimal medical therapy in patients undergoing coronary PCI does not change events rate...
solaci -
Ver más
Acute coronary syndromes

Can Aspirin Use Be Interrupted After Angioplasty?

Aspirin discontinuation 1 to 3 months after angioplasty with continued P2Y12 inhibitor therapy reduces the bleeding risk without...
solaci -
Ver más
Chronic Ischemic cardiopathy

IVUS in Every Step of Complex Angioplasty

Complex angioplasties require not only experience and patience but also technology. Imaging–guided pre-dilation, stent sizing, and post-dilation...
solaci -
Ver más
Chronic Ischemic cardiopathy

Randomized Evidence on the Helpfulness of Yoga for Cardiac Rehabilitation

This work brings us evidence that yoga-based cardiac rehabilitation improves how patients feel about their health and...
solaci -
Ver más
Chronic Ischemic cardiopathy

Quantitative Angiography that Estimates Shear Stress and Predicts Events

Shear stress has been incorporated to our jargon to identify this turbulent flow in certain places of...
solaci -
Ver más
Chronic Ischemic cardiopathy

Differences in Plaque Progression Depending on its Characteristics

The pattern of growth for each plaque differs according to the presence of certain risk factors. Atheroma...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad